Biologic Drugs

Aug 01, 2012
Pharmaceutical Technology
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
Jul 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Holistic open learning networks offer a new drug R&D model for improving research outcomes.
Jun 20, 2012
Equipment and Processing Report
By Pharmaceutical Technology Editors
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.
Jun 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Does global development have to entail multiple comparability studies?
Jun 02, 2012
Pharmaceutical Technology
Partnerships between industry and academic medical centers are expanding to meet R&D needs.
Jun 02, 2012
Pharmaceutical Technology
Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
May 02, 2012
Pharmaceutical Technology
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
May 02, 2012
PTSM: Pharmaceutical Technology Sourcing and Management
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
May 01, 2012
Pharmaceutical Technology
In this technical forum, experts describe different methods of rapid microbial testing and their applications.
Apr 05, 2012
ePT--the Electronic Newsletter of Pharmaceutical Technology
On Mar. 29, 2012, the Generic Pharmaceutical Association reiterated its call for Congress to move forward with user-fee proposals for generic drugs and biosimilar products.
native1_300x100
lorem ipsum